Fresenius Kabi
Sarujan Sountararajah has extensive experience in the pharmaceutical industry, currently serving as Manager of Sterile Manufacturing Operations/AQPIC at Fresenius Kabi since October 2009. In this role, Sarujan focuses on process improvement by analyzing and enhancing manufacturing processes to ensure efficiency, quality, and regulatory compliance. Additionally, Sarujan is responsible for developing and implementing manufacturing protocols in accordance with industry standards such as USP 797 and NAPRA. Prior to this position, Sarujan held roles ranging from Sterile Compounding/Operation Supervisor to Cleanroom Technician at Fresenius Kabi, and gained valuable experience as a Pharmacy Technician Student at both Southlake Hospital and Medical Pharmacies Group Limited.
This person is not in any teams
This person is not in any offices
Fresenius Kabi
15 followers
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients. Fresenius Kabi’s product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the devices for administering these products. In the field of biosimilars, Fresenius Kabi focuses on autoimmune diseases and oncology. In 2019, the first biosimilar product by Fresenius Kabi was launched. Within transfusion medicine and cell therapies, Fresenius Kabi offers products for collection of blood components and extracorporeal therapies.